Cargando…

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma

The chromodomain helicase DNA binding domain 5 (CHD5) is required for neural development and plays an important role in the regulation of gene expression. Although CHD5 exerts a broad tumor suppressor effect in many tumor types, its specific functions regarding its expression levels, and impact on i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lei, Shao, Fengling, Luo, Tengling, Li, Qijun, Tan, Dongmei, Tan, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369136/ https://www.ncbi.nlm.nih.gov/pubmed/35955624 http://dx.doi.org/10.3390/ijms23158489

Ejemplares similares

GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma
por: Luo, Tengling, et al.
Publicado: (2022)

HPGDS is a novel prognostic marker associated with lipid metabolism and aggressiveness in lung adenocarcinoma
por: Shao, Fengling, et al.
Publicado: (2022)

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
por: Soltan, Mohamed A., et al.
Publicado: (2023)

The mitosis-related gene OIP5 is a potential biomarker in pan-cancer
por: Pan, Minghong, et al.
Publicado: (2023)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort
por: Tian, Chong, et al.
Publicado: (2016)

The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer
por: Chen, Xiaowei, et al.
Publicado: (2023)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

CHD5 inhibits metastasis of neuroblastoma
por: Laut, Astrid K., et al.
Publicado: (2021)

Corrigendum: Green tea consumption is associated with reduced incident CHD and improved CHD-related biomarkers in the Dongfeng-Tongji cohort
por: Tian, Chong, et al.
Publicado: (2017)

Differential Expression and Sex Chromosome Association of CHD3/4 and CHD5 during Spermatogenesis
por: Bergs, Judith W., et al.
Publicado: (2014)

CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis
por: Han, Lu, et al.
Publicado: (2023)

Pan‑cancer analysis identified ARHGAP23 as a potential biomarker for pancreatic adenocarcinoma
por: Liu, Xiaolong, et al.
Publicado: (2023)

Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
por: Li, Yongsheng, et al.
Publicado: (2020)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

Transcriptome and pan-cancer system analysis identify PM2.5-induced stanniocalcin 2 as a potential prognostic and immunological biomarker for cancers
por: Zhu, Dong, et al.
Publicado: (2023)

Packing for the journey: CHD5 remodels the genome
por: Li, Wangzhi, et al.
Publicado: (2014)

Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
por: Qiu, Yingqi, et al.
Publicado: (2022)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy
por: Zhang, Hao, et al.
Publicado: (2020)

The single-nucleotide polymorphisms in CHD5 affect the prognosis of patients with hepatocellular carcinoma
por: Zhu, Xiao, et al.
Publicado: (2017)

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosis
por: Xie, Yingbin, et al.
Publicado: (2019)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma
por: Yu, Lei, et al.
Publicado: (2015)

Silencing of CHD5 Gene by Promoter Methylation in Leukemia
por: Zhao, Rui, et al.
Publicado: (2014)

Oral health status of CHD and non-CHD adults of Lahore, Pakistan
por: Bokhari, Syed Akhtar Hussain, et al.
Publicado: (2011)

Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer
por: Yu, Yang, et al.
Publicado: (2023)

Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
por: Zhou, Yong, et al.
Publicado: (2022)

Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
por: Zhou, Libo, et al.
Publicado: (2023)

Potential Metabolic Biomarkers to Identify Interstitial Lung Abnormalities
por: Tan, Yong, et al.
Publicado: (2016)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

Progress in CHD Prevention
por: Lewis, Barry
Publicado: (1983)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

CHD1 and CHD2 are positive regulators of HIV-1 gene expression
por: Rodgers, Melissa J, et al.
Publicado: (2014)

Expression of Hcy and blood lipid levels in serum of CHD patients and analysis of risk factors for CHD
por: Liu, Weijing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_65q6nbv32o2tg2il6hd01kiue4